@FierceBiotech: Westphal leaving SR One, concentrating on VC firm. News | Follow @FierceBiotech
@JohnCFierce: Inspire Pharma hit a wall in January when its CF drug flunked a Ph3. Merck is picking up the opthalmology pieces in the debris. | Follow @JohnCFierce
> Those CVRs Sanofi offered to complete the Genzyme acquisition started trading at $2.30. Story
> Incyte scored a $15 million milestone payment from Novartis based on the ongoing Phase I dose-escalation trial for INCB28060 (also known as INC280) in patients with solid tumors. Incyte release
> The FDA has approved an extended release version of Viramune, Boehringer's HIV drug. Story
> Champions Oncology has completed the private placement of 12.5 million shares of its common stock at a price of $0.75 per share, proving $9.4 million in financing. Report
Pharma News
@FiercePharma: Analysts: Expect more hostile bids in pharma. Story | Follow @FiercePharma
> Merck nabs eye specialist Inspire for $430M. Report
> Drugmakers: Canada-EU trade deal won't cost billions. Article
> Bankers expect more Japanese-led M&A. News
> Early hep C drug pricing spooks experts. Story
> Bayer to combine East Coast ops in NJ. Report
> Data questions Avastin safety for eye use. Article
Research News
> Former football player now studies athletes' genes. News
> Gene-patent courtroom drama plays out in Washington. Article
> Alzheimer's researchers have five new genes to ponder. Report
> Israeli biotech Pluristem uses stem cells from placentas. Story
> Nanoparticles provide protection against nickel allergies. Item
> Coming soon: 3D adult stem cells, no glasses required. Report
Manufacturing News
> India marks its fifth $1B drugmaker. Story
> Roche, Catalent suffer warehouse fires. Item
> McNeil consent decree quarantine helps J&J's bottom line. Report
> Merck, Roche add voice to pick operations. Article
> PAT, QbD spur continuous processing. News
> DNA links Lilly, GSK warehouse thefts. Report
And Finally... Investigators at UT Southwestern Medical Center say they have discovered how to block a dangerous spike in blood pressure often seen in patients suffering from hypertension when they exercise. Report